Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 319

1.

Safety and tolerability of sedation-free flexible cystoscopy for intradetrusor botulinum toxin-A injection.

Cohen BL, Rivera R, Barboglio P, Gousse A.

J Urol. 2007 Mar;177(3):1006-10; discussion 1010.

PMID:
17296397
2.

[Prospective study of the clinical and urodynamic results of intradetrusor botulinum toxin injections for the treatment of neurogenic overactive bladder].

Bentaleb Y, Castel-Lacanal E, Sallusto F, De Boissezon X, Malavaud B, Marque P, Rischmann P, Gamé X.

Prog Urol. 2008 Jul;18(7):449-55. doi: 10.1016/j.purol.2008.03.014. Epub 2008 May 27. French.

PMID:
18602606
3.

Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux.

Karsenty G, Elzayat E, Delapparent T, St-Denis B, Lemieux MC, Corcos J.

J Urol. 2007 Mar;177(3):1011-4.

PMID:
17296399
4.

Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.

Schmid DM, Sauermann P, Werner M, Schuessler B, Blick N, Muentener M, Strebel RT, Perucchini D, Scheiner D, Schaer G, John H, Reitz A, Hauri D, Schurch B.

J Urol. 2006 Jul;176(1):177-85.

PMID:
16753396
5.
6.

Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup.

Giannantoni A, Porena M, Costantini E, Zucchi A, Mearini L, Mearini E.

J Urol. 2008 Mar;179(3):1031-4. doi: 10.1016/j.juro.2007.10.032. Epub 2008 Jan 18.

PMID:
18206941
7.

Effectiveness of botulinum-A toxin for the treatment of refractory overactive bladder in children.

Marte A, Borrelli M, Sabatino MD, Balzo BD, Prezioso M, Pintozzi L, Nino F, Parmeggiani P.

Eur J Pediatr Surg. 2010 May;20(3):153-7. doi: 10.1055/s-0029-1246193. Epub 2010 Jan 28.

PMID:
20112186
8.

Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review.

Karsenty G, Denys P, Amarenco G, De Seze M, Gamé X, Haab F, Kerdraon J, Perrouin-Verbe B, Ruffion A, Saussine C, Soler JM, Schurch B, Chartier-Kastler E.

Eur Urol. 2008 Feb;53(2):275-87. Epub 2007 Oct 16. Review.

PMID:
17988791
9.

Re: Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity.

Sahai A, Dowson C, Khan MS, Dasgupta P.

BJU Int. 2008 Feb;101(4):515-6; author reply 516-7. doi: 10.1111/j.1464-410X.2008.07447_3.x. No abstract available.

10.

Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity.

Apostolidis A, Jacques TS, Freeman A, Kalsi V, Popat R, Gonzales G, Datta SN, Ghazi-Noori S, Elneil S, Dasgupta P, Fowler CJ.

Eur Urol. 2008 Jun;53(6):1245-53. doi: 10.1016/j.eururo.2008.02.037. Epub 2008 Mar 7.

PMID:
18343564
11.
12.

[Botulinum toxin type A in patients with overactive bladder].

Krivoborodov GG, Vasil'ev AV, Shumilo DV, Ivanov AV, Tur EI.

Urologiia. 2010 May-Jun;(3):36-40. Russian.

PMID:
20734876
13.

Short-term efficacy of botulinum toxin a for refractory overactive bladder in the elderly population.

White WM, Pickens RB, Doggweiler R, Klein FA.

J Urol. 2008 Dec;180(6):2522-6. doi: 10.1016/j.juro.2008.08.030. Epub 2008 Oct 19.

PMID:
18930481
14.

What a patient with refractory idiopathic detrusor overactivity should know about botulinum neurotoxin type a injection.

Khan S, Kessler TM, Apostolidis A, Kalsi V, Panicker J, Roosen A, Gonzales G, Haslam C, Elneil S, Fowler CJ, Dasgupta P.

J Urol. 2009 Apr;181(4):1773-8. doi: 10.1016/j.juro.2008.11.110. Epub 2009 Feb 23.

PMID:
19233414
15.

EMLA cream application without occlusive dressing before upper facial botulinum toxin injection: a randomized, double-blind, placebo-controlled trial.

Kashkouli MB, Salimi S, Bakhtiari P, Parvaresh MM, Sanjari MS, Naseripour M.

Ann Plast Surg. 2008 Apr;60(4):353-6. doi: 10.1097/SAP.0b013e31812f6e0f.

PMID:
18362558
16.
17.

Lidocaine tape (Penles) reduces the pain of botulinum toxin injection for Meige syndrome.

Onguchi T, Takano Y, Dogru M, Ono M, Tsubota K.

Am J Ophthalmol. 2004 Oct;138(4):654-5.

PMID:
15488799
19.

Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder.

Haferkamp A, Schurch B, Reitz A, Krengel U, Grosse J, Kramer G, Schumacher S, Bastian PJ, Büttner R, Müller SC, Stöhrer M.

Eur Urol. 2004 Dec;46(6):784-91.

PMID:
15548448
20.

Supplemental Content

Support Center